Pre-earnings options volume in Cidara Therapeutics is 3.2x normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 20.0%, or 34c, after results are released. Median move over the past eight quarters is 2.5%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CDTX:
- Cidara Therapeutics Announces Pricing of Public Offerings of Common Stock and Preferred Stock
- Cidara Therapeutics 11.8M share Spot Secondary priced at $1.40
- Cidara Therapeutics Announces Underwritten Public Offerings of Common Stock and Preferred Stock
- Cidara Therapeutics announces common stock, preferred stock offerings
- Cidara Therapeutics announces interim Phase 2a data of CD388